Dental Implant Failed Clinical Trial
Official title:
COMPARISON OF IMPLANT INSTALLATION USING THE TRANSCRESTAL APPROACH WITH OSSEODENSIFICATION OR THE LATERAL WINDOW TECHNIQUE WITH SINUS LIFT: A RANDOMIZED CONTROLLED TRIAL.
Verified date | November 2022 |
Source | Federal University of Rio Grande do Sul |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will compare patient-reported outcomes, as well as the type and incidence of complications, and bone marginal loss after 12 months in implants installed using the transcrestal approach (tSFE) with an osseodensification system (performed according to the protocol by Huwais et al. 2018), or installed simultaneously using the lateral window technique (lSFE) with sinus lift. A blind, randomized, controlled clinical trial will be carried out with individuals over 18 years old, and with single tooth loss in the posterior maxilla, where the residual bone height (RBH) is 3 to 5 mm. The tSFE will be performed with osseodensification burs (Densa Bur, Versah, USA) using a counterclockwise motion, associated to synthetic biomaterial (hydroxyapatite and beta-tricalcium phosphate). The lSFE technique will require the sinus to be filled with the same biomaterial as the group using the other technique, and the antrostomy to be covered with a polydioxanone-based membrane. The patient's post-operatory perceptions will be evaluated by self-administered questionnaires quantifying social and professional isolation, physical appearance, duration and changes in quality of life, eating and speech, diet variations, and sleep deficiency for 2 weeks after the procedure. Pain will be assessed with the visual analogue scale (VAS). Immediately after prosthetic rehabilitation, cone beam tomography will be performed. Controls at 6 and 12 months will be performed. In these images, the marginal bone level in relation to a fixed reference point on the implants (upper part of the platform) will be measured mesially and distally in each implant, using a specific program (ImageJ - version 1.49v / NIH software - Bethesda, MD, USA). Generalized estimating equations will be used to compare the two treatments overtime. The significance level used will be 0.05.
Status | Recruiting |
Enrollment | 38 |
Est. completion date | October 1, 2026 |
Est. primary completion date | October 1, 2026 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | All |
Age group | 18 Years and older |
Eligibility | Inclusion Criteria: - Maxillary sinuses that have residual bone height between at least 3 mm and 5 mm; - Width of the residual bone ridge that allows the insertion of an implant with a diameter of 4 mm; - Tomographic thickness of Schneider's membrane with a maximum of 5 mm in the region to be operated; - Residual ridge with =2 mm of medullary bone in the bucco-palatal direction, with a 1/1 ratio of medullary and cortical bone to achieve predictable plastic expansion; - Patients with adequate interarch space for placement of the prosthetic crown; - Good physical health status (ASA1 and ASA2, according to the Physical Status Classification System - American Society of Anesthesiologists); - At least 6 months since the last tooth loss in the region to be operated; Exclusion Criteria: - - Those with sinus pathology; - Heavy smokers (more than 10 cigarettes a day); - Those with a history of head and neck radiotherapy; - Those who have already undergone bone augmentation in any of the targeted surgical areas; - Immunodeficiency of any nature; - Emotional instability and psychiatric problems; - Pregnancy; - Current use of oral bisphosphonates or history of using injectable bisphosphonate; - Patients with active periodontitis defined by the presence of subgingival bleeding greater than 10%; - Documented allergy to drugs or dental materials involved in the experimental protocol. |
Country | Name | City | State |
---|---|---|---|
Brazil | Alex Haas | Porto Alegre | Rio Grande Do Sul |
Lead Sponsor | Collaborator |
---|---|
Federal University of Rio Grande do Sul |
Brazil,
Bacevic M, Compeyron Y, Lecloux G, Rompen E, Lambert F. Intraoperative and postoperative outcomes of sinus floor elevation using the lateral window technique versus the hydrodynamic transalveolar approach: a preliminary randomized controlled trial. Clin O — View Citation
Farina R, Franceschetti G, Travaglini D, Consolo U, Minenna L, Schincaglia GP, Riccardi O, Bandieri A, Maietti E, Trombelli L. Morbidity following transcrestal and lateral sinus floor elevation: A randomized trial. J Clin Periodontol. 2018 Sep;45(9):1128-1139. doi: 10.1111/jcpe.12985. Epub 2018 Aug 3. — View Citation
Franceschetti G, Rizzi A, Minenna L, Pramstraller M, Trombelli L, Farina R. Patient-reported outcomes of implant placement performed concomitantly with transcrestal sinus floor elevation or entirely in native bone. Clin Oral Implants Res. 2017 Feb;28(2):1 — View Citation
Huwais S, Mazor Z, Ioannou AL, Gluckman H, Neiva R. A Multicenter Retrospective Clinical Study with Up-to-5-Year Follow-up Utilizing a Method that Enhances Bone Density and Allows for Transcrestal Sinus Augmentation Through Compaction Grafting. Int J Oral — View Citation
Huwais S, Meyer EG. A Novel Osseous Densification Approach in Implant Osteotomy Preparation to Increase Biomechanical Primary Stability, Bone Mineral Density, and Bone-to-Implant Contact. Int J Oral Maxillofac Implants. 2017 Jan/Feb;32(1):27-36. doi: 10.1 — View Citation
Pikos MA, Miron RJ. To Drill or to Densify? Clinical Indications for the Use of Osseodensification. Compend Contin Educ Dent. 2019 May;40(5):276-281; quiz 282. — View Citation
Starch-Jensen T, Bruun NH. Patient's perception of recovery after osteotome-mediated sinus floor elevation with Bio-Oss collagen compared with no grafting material: a randomized single-blinded controlled trial. Int J Implant Dent. 2021 Mar 22;7(1):20. doi — View Citation
Starch-Jensen T, Jensen JD. Maxillary Sinus Floor Augmentation: a Review of Selected Treatment Modalities. J Oral Maxillofac Res. 2017 Sep 30;8(3):e3. doi: 10.5037/jomr.2017.8303. eCollection 2017 Jul-Sep. — View Citation
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Level of discomfort | Level of discomfort as recorded on a 5-point rating scale ranging from "no discomfort"; "little discomfort"; "discomfort"; "a lot of discomfort" and "very high discomfort" | as recorded on day 0 (night), +1, +2, +3, +4, +7, and +14, | |
Other | Limitations in daily functions | Limitations in daily functions (i.e. swallowing, breathing, continuing daily activities, eating, speaking, opening the mouth), on a 5-point rating scale ranging from "no limitations" to "unable to eat all kinds of food" (for the item "eat"), and from "no difficulty" to "extreme difficulty" (for the other items ); | as recorded on day 0 (night), +1, +2, +3, +4, +7 and + 14 | |
Other | Incidence of postoperative signs and symptoms | Incidence of swelling, nausea, bruising, nasal discharge/bleeding, nasal stuffiness, bad taste/smell | day 0 (night), +1, +2, +3, +4, +7 and +14; | |
Other | Willingness to undergo the same type of surgery | a 4-point rating scale ranging from "no problem to repeat surgery if needed" to "I will never have this type of surgery again." | recorded on day +14 | |
Other | Clinical Outcomes | Membrane perforation (yes or no) will be evaluated during the transoperative period. In addition, the following clinical outcomes will be evaluated: Face edema (yes or no);
Facial hematoma (yes or no); Presence of suppuration; Suture dehiscence. |
7 and 14 days after surgery | |
Other | Cinical evaluation of Implant failure | Implant loss may occur during the phase of osseointegration (early) or at a later time when the previously achieved osseointegration is lost (late). Implant loss defined by lack of osseointegration represented by mobility, and will be assessed at throughout the entire search | through study completion, an average of 18 months | |
Other | Peri-implant clinical examinations | probing depth in millimeters will be evaluated at six sites per implant (mesiobuccal, buccal, distobuccal, and mesiolingual/palatal, lingual/palatal, distolingual/palatal). | 1 and 12 months after the installation of the prosthesis | |
Other | Peri-implant clinical examinations | submucosal bleeding points after probing will be evaluated at six sites per implant (mesiobuccal, buccal, distobuccal, and mesiolingual/palatal, lingual/palatal, distolingual/palatal). | 1 and 12 months after the installation of the prosthesis | |
Other | Tomographic outcomes | The images will be used to measure the marginal bone level mesially and distally in each implant, in relation to a fixed reference point on the implants (upper part of the platform), using a specific program (ImageJ) | 1 and 12 months after the installation of the prosthesis | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst imaginable pain" | baseline | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 1 | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 2 | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 3 | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 4 | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 7 | |
Primary | Pain level | visual analogue scale (VAS), ranging from "0 - no pain" to "100 - worst | day 14 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | baseline | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 1 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 2 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 3 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 4 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 5 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 6 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 7 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 8 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 9 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 10 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 11 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 12 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 13 | |
Secondary | Medication Diary (number of doses of Ibuprofen 600mg) | Rescue anti-inflammatory drug dosage (i.e. number of ibuprofen 600 mg tablets), and name of other types of drugs taken as of the day of surgery up to the 14th postoperative day, recorded daily in a medication diary | day 14 |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04370314 -
Retrospective Study on Clinical Performance of Screw-retained Implant Crowns
|
N/A | |
Completed |
NCT04620018 -
Comparison of Three Antibiotic Protocols in Prevention of Infection in Dental Implant Surgery
|
N/A | |
Recruiting |
NCT04073654 -
SA Versus SOI Surfaces for Single Implant-supported Crown
|
N/A | |
Completed |
NCT05739461 -
The Effect of Triangular Neck Design on Crestal Bone Loss
|
||
Not yet recruiting |
NCT05973357 -
The Influence of Vertical Implant Position With Immediate Provisionalization on the Marginal Bone Loss.
|
N/A | |
Completed |
NCT06099834 -
Evaluation of Osseointegration Process of Dental Implants
|
N/A | |
Active, not recruiting |
NCT06034067 -
Osseodensification Versus Conventional Drilling for Implant Site Preparation
|
N/A | |
Recruiting |
NCT04983758 -
20-year Implant Survival in Periodontally Healthy and Compromised Patients
|
||
Completed |
NCT03641365 -
Sleeves Versus Sleeveless Template
|
N/A | |
Completed |
NCT05724706 -
An Evaluation of Salivary Oxidant and Antioxidant Levels in Peri-implant Health and Disease
|
||
Completed |
NCT04270396 -
Early and Late Implant Failure
|
||
Completed |
NCT05060055 -
Digital Assessment at Peri-implant Tissues After Immediate Implants With Customized Healing Abutments and Connective Tissue Grafts
|
N/A | |
Recruiting |
NCT04429373 -
Effect of Platelet-rich Plasm (PRF) on Two-implant Mandibular Overdenture: a Split Mouth
|
N/A | |
Not yet recruiting |
NCT03741036 -
Immediate Implant Placement With Provisionalization Using Different Bone Grafts as a Space Filling Material in the Maxillary Esthetic Zone
|
N/A | |
Completed |
NCT02625597 -
Assessment of the Effects of Different Implant Abutment Occluding Materials on Dental Implant Health Parameters and Microbiology
|
N/A | |
Completed |
NCT03720236 -
Peri-implant Tissues in BLX® Implants
|
N/A | |
Active, not recruiting |
NCT04518020 -
Single Crown Supported by Short Implant Versus Standard Implant in Conjunction With Maxillary Sinus Floor Augmentation.
|
N/A | |
Completed |
NCT06294171 -
Efficacy of Modified Piezosurgery Alveolar Bone Cut With Osseodensification Drills in Expanding Narrow Alveolar Bone
|
N/A | |
Withdrawn |
NCT03715439 -
Evaluation of Dental Implants Placed in Preserved and Non-preserved Post-extraction Ridges
|
||
Completed |
NCT05754970 -
Clinical, Prospective, Non-profit, Non-pharmacological Study on Geass Healing Abutment: Microbiological, Histological, and Immuno-histochemical Evaluation.
|
N/A |